Protein phosphatase 1 (PP1) belongs to a class of protein serine/threonine phosphatases that include metal-dependent protein phosphatases (PPMs) and aspartate-based phosphatases. PP1 plays an important role in many biological processes, including glycogen metabolism, muscle contraction, cell growth, neural activity, RNA splicing, mitosis, cell division, apoptosis, protein synthesis, and the regulation of membrane receptors and channels.
Each PP1 enzyme consists of a catalytic subunit and at least one regulatory subunit. The catalytic subunit consists of a 30-kD single-domain protein that is able to form a complex with other regulatory subunits. This catalytic subunit is highly conserved in all eukaryotes, showing a common catalytic mechanism. Regulatory subunits play important roles in substrate specificity and spatial localization. Some common regulatory subunits include GM (PPP1R3A) and GL (PPP1R3B), which are named after their sites of action in muscle and liver, respectively. While the yeast S. cerevisiae encodes only one catalytic subunit, mammals have three genes encoding four isoforms, each of which attracts a different regulatory subunit.
X-ray crystallographic structural data revealed that the catalytic subunit of PP1 forms an α/β fold with a central β-sandwich sandwiched between two α-helical domains. The interaction of these three β sheets forms a catalytically active channel and serves as a coordination site for metal ions.
The catalytic process involves the binding of two metal ions, which activate water molecules to initiate a nucleophilic attack on the phosphorus atom. The subtlety of this process lies in the selective regulation of metals and the accurate reaction of substrates.
Potential inhibitors include various naturally occurring toxins, such as the Pacific shellfish toxin okadaic acid, a diarrhoeal toxin and potent tumor promoter, and microcystins. Microcystins are hepatotoxins produced by blue-green algae and contain a cyclic heptapeptide structure that can interact with three different regions of the PP1 catalytic subunit.
Studies have shown that when microcystin forms a complex with PP1, the structure of the catalytic subunit of PP1 changes to avoid hydrogen bond competition and ensure that its catalytic activity is not affected.
In the liver, PP1 plays a key role in regulating blood glucose levels and glycogen metabolism. It ensures the counter-regulation of glycogenolysis and synthesis, which is crucial for energy balance. The key regulator of PP1 is glycogen phosphorylase a, which serves as a glucose sensor in hepatocytes.
When glucose levels are low, phosphorylase a in the active R state binds tightly to PP1, thereby inhibiting the phosphatase activity of PP1. When the glucose concentration increases, phosphorylase a switches to the inactive T state, PP1 dissociates and begins to activate glycogen synthase.
The latest research indicates that Akt (protein kinase B) directly phosphorylates the PP1 regulatory subunit PPP1R3G and promotes its binding to the PP1 complex, thereby activating the phosphatase activity of PP1.
In Alzheimer's disease, hyperphosphorylation of microtubule-associated proteins inhibits microtubule assembly in neurons. Studies have shown that PP1 activity is significantly reduced in the gray matter of patients with Alzheimer's disease, suggesting a potential role for the dysfunctional phosphatase in the disease process.
In addition, PP1 also plays an important role in the regulation of HIV-1 transcription, and its inhibition can affect the virus's ability to replicate, making PP1 a new focus of therapeutic research.
The diverse functions and clinical significance of protein phosphatase 1 remind us to understand the complexity of intracellular signal transduction. What unexpected discoveries and challenges may it bring in future biomedical research?